Conceptual study of Non-Alcoholic Fatty Liver Disease and its management in Ayurveda
Abstract
Non-alcoholic Fatty liver Disease (NAFLD) is a condition with excessive fat deposition in liver on refers to a broad spectrum of disorders characterized by fatty infiltration of the liver steatosis, steatohepatitis and cirrhosis. It is a growing cause of liver injury globally and is present in developed and developing countries. NAFLD is a broad term which describes the build up of excessive fat in the liver cells (hepatocytes) in the absence of excessive alcohol intake. It is a growing worldwide, due to obesity and insulin resistance leading to liver accumulation of triglycerides and free fatty acids. NAFLD encompasses a spectrum of liver Pathology with different clinical prognoses, from the simple accumulation of triglycerides within hepatocytes to more progressive steatosis with associated hepatitis, fibrosis, cirrhosis and in some cases hepatocellular Carcinoma. It is a global epidemic that ranges from isolated hepatic steatosis (NAFL) to Steatosis Plus inflammation (NASH) with or without fibrosis. Ayurveda described different types of Non-Communicable diseases, and NAFLD is one among them. In Ayurveda NAFLD can be interpreted as a Santarpanotha Vikara caused by Kapha Medo Dushti, getting Sthanasamshraya in Yakrit, which is Raktavaha Srotasmula and Pittasthana. In the initial stage of NAFLD, Kapha Meda Dushti occurs when Pitta gets involved in the pathogenesis, inflammatory changes occur which leads to the next stage of disease i.e., Non alcoholic steatohepatitis (NASH), When Vata comes involved fibrosis occurs which may end up in cirrhosis. So, the management should be the breakdown of pathological factors like Agnivaigunya, Srotorodha and Kaphamedo Dushti. This review will give a better knowledge of etiopathogenesis.
Downloads
References
Sastri kasinath Chaturvedi Gorkhnath, Charaka Samhita. Chaukhamba Bharti Academy (2020), Charaka chikitsa sthana 13th chapter.
Sastri Ambikadutta, Sushruta Samhita, Chaukhambha Sanskrit sansthana (2018), Sushruta nidana sthana 7th chapter.
Sastri Ambikadutta, Sushruta Samhita, Chaukhambha Sanskrit sansthana (2018), Sushruta sharira sthana 4th chapter.
Gupta Atrideva, Ashtanga Sangraha, Chaukhambha prakashan (2015) Vagbhatta Nidana sthana 12th chapter.
Murthy Srikantha Prof. K, Acharya vagbhata, Ashtang Hridaya, English translation Chowkhambha Krishnadas Academy (2016) Nidana sthana 12th chapter, shloka 28.
Murthy K.R. Srikantha, Bhavaprakasha Samhita, Chaukhambhasansthan (2009), Bhavaprakasha Madhyama khanda 33rd chapter.
Yogesh K Chawla, Sunil Taneja, API Textbook of Medicine, 9th edition, Vol.1, Sec. 14, Ch. 11, Jaypee Brothers Medical Publishers (P) Ltd., 2012, p. 885-887.
Munjal Y. Pal, API text book of medicine, vol-2, section-24, 9th Ed. The Association of Physicians of India, 2012; 68, 76, 95, 103.
J.D.Collier, G. Webster, Davidson’s Principles and Practise of Medicine, 21st Edition, Part 2, Ch. 23, Churchill Livingstone Elsevier, 2010,p.956-957.
National Guideline Centre (UK). Non-Alcoholic Fatty Liver Disease: Assessment and Management. London: National institute for Health and Care Excellence (UK); 2016 Jul. [NICE Guideline, No. 49.] 6, Diagnosis of NAFLD. Available from: https://www.ncbi.nlm.nih.gov/books/NBK384715/
ANGULO PAUL AND LINDOR D KEITH. Non-alcoholic fatty liver disease Journal of Gastroenterology and Hepatology, 2002; 17: S186-S190.
Farrel GC, Larter CZ. Non-alcoholic Fatty Liver Disease: from steatosis to cirrhosis. Hepatology, 2006; 43: S00-S112.
Duseja A, Das A, Das R, Dhiman R, Chawla Y. Non alcoholic steatohepatitis : our experience Indian J. Gastroenterol. 2004; 23 (suppl.1): S25.
Chavez-Tapia NC, Tiribelli C: Are non-invasive tests accurate enough to predict hepatic fibrosis in non-alcoholic Fatty liver disease (NAFLD)? Gut, 2008; 57: 1351-3
Day CP, James OF. Steatohepatitis: A tale of two “hits” Gasenterology, 1998
Andy S. Yu, MD, Emmet B, Keeffe, Non alcoholic Fatty Liver Disease. DOI 10.1007/s12664-010-0069-1[Rev Gastroenterol Disord, 2002; 2(1):11-19.
National Guideline Centre (UK). Non-Alcoholic Fatty Liver Disease: Assessment and Management. London: National Institute for Health and Care Excellence (UK); 2016 Ju.
Patel V, Sanyal AJ, Sterling R. Clinical Presentation and Patient Evaluation in Non Alcoholic Fatty Liver Disease. Clin Liver Dis.2016; 20:277-292.
James M. Paik, Seema Mir, Saleh A. Alaqahtani, Youssef Younossi, Janus P. Ong, Zobair M. Younossi; Dietary Risks for Liver Mortality in NAFLD.
World J Hepatol. 2017 Jun 8; 9(16): 715-732; Published online 2017 Jun 8. doi: 10.4254/wjh.v9.i16.715.
Copyright (c) 2024 Pooja Hui, Sonalika Jena, Snehamayee Mishra
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Ayurveda and Integrated Medical Sciences (JAIMS) retains the copyright of the contents of this journal but grant the readers the right to use the contents with terms and conditions under a creative common attribution licenses 4 of Attribution, Share Alike and Non-commercial type (CC BY-NC-SA) that allows copy, distribute, display, and perform the work and make derivative works based on it only for non-commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.